General Information of the Compound
Compound ID |
CP0034885
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
CHEBI:204928
Show/Hide
|
||||||||||||||||||
Synonyms |
CE3
Cefotaxim
Cefotaxim Hikma
Cefotaxim Hikma (TN)
Cefotaxima
Cefotaxima [INN-Spanish]
Cefotaxime
Cefotaxime (INN)
Cefotaxime [INN:BAN]
Cefotaxime acid
Cefotaximum
Cefotaximum [INN-Latin]
Cephotaxim
Cephotaxime
Claforan
Claforan (*Sodium salt*)
Claforan (TN)
Klaforan
RU 24662
Ru-24756
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H17N5O7S2
|
||||||||||||||||||
Molecular Weight |
455.474
|
||||||||||||||||||
Canonical SMILES |
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(C)=O)=C(N2C1=O)C(O)=O)c1csc(N)n1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
GPRBEKHLDVQUJE-QSWIMTSFSA-N
|
||||||||||||||||||
CAS |
63527-52-6
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02209, Organic anion transporter 3
Protein ID: PT02208, Solute carrier family 22 member 11
Protein ID: PT04064, Solute carrier family 22 member 6
Clinical Information about the Compound